Mark Pool

35.7k total citations
13 papers, 293 citations indexed

About

Mark Pool is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mark Pool has authored 13 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Mark Pool's work include Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (3 papers) and Lung Cancer Research Studies (3 papers). Mark Pool is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (3 papers) and Lung Cancer Research Studies (3 papers). Mark Pool collaborates with scholars based in United States and Canada. Mark Pool's co-authors include John S. Coon, Kathleen M. Darcy, William T. Beck, Xijing He, S B Lim, Nelly Auersperg, Ahmet Arslan, Philip Bonomi, Bruce C. McLeod and Sanjib Basu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Mark Pool

12 papers receiving 285 citations

Peers

Mark Pool

ONCOL

PRM

IMMUN

Ana Loizaga‐Iriarte Spain

Monica Nesselbush United States

Rabab A. Ahmed Egypt

Wei Qiu China

Lu Pei China

Montserrat Torà Spain

Dennis Poel Netherlands

Samira Taeb Canada

Annalisa Comandatore Italy

Wayne Glover United States

Ana Loizaga‐Iriarte Spain

Mark Pool

254 ×1.2

158 ×1.8

51 ×1.0

ONCOL

67 ×2.1

PRM

30 ×1.3

IMMUN

Citations per year, relative to Mark Pool Mark Pool (= 1×) peers Ana Loizaga‐Iriarte

Countries citing papers authored by Mark Pool

Since Specialization

Citations

This map shows the geographic impact of Mark Pool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Pool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Pool more than expected).

Fields of papers citing papers by Mark Pool

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Pool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Pool. The network helps show where Mark Pool may publish in the future.

Co-authorship network of co-authors of Mark Pool

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Pool. A scholar is included among the top collaborators of Mark Pool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Pool. Mark Pool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pool, Mark, et al.. (2021). Biphenotypic sinonasal sarcoma: Report of 3 cases with a review of literature. SHILAP Revista de lepidopterología. 24. 200491–200491. 10 indexed citations

Seder, Christopher W., et al.. (2020). A Case of Vanishing Thymoma. The Annals of Thoracic Surgery. 110(2). e107–e109.

Fidler, Mary J., Cristina Fhied, Joanna Roder, et al.. (2018). The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients. BMC Cancer. 18(1). 310–310. 32 indexed citations

Fhied, Cristina, et al.. (2018). Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum. Journal of Immunoassay and Immunochemistry. 39(1). 84–98. 6 indexed citations

Fidler, Mary J., Casey Frankenberger, Cristina Fhied, et al.. (2017). Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy. Oncotarget. 8(35). 58108–58121. 9 indexed citations

Gattuso, Paolo, et al.. (2012). CDKN2A (p16) Promoter Hypermethylation Influences the Outcome in Young Lung Cancer Patients. Diagnostic Molecular Pathology. 21(4). 207–213. 22 indexed citations

Kaplan, Keith J., Bruce A. Friedman, & Mark Pool. (2010). Ten important lessons we have learned as pathology bloggers. Journal of Pathology Informatics. 1(1). 20–20. 2 indexed citations

Hensing, Thomas A., Mary J. Fidler, Fuh Yong Wong, et al.. (2010). The association between PTEN expression and survival in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with erlotinib.. Journal of Clinical Oncology. 28(15_suppl). 7552–7552. 1 indexed citations

He, Xijing, Ahmet Arslan, Mark Pool, et al.. (2010). Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene. 30(3). 356–365. 83 indexed citations

10.

Fidler, Mary J., Sreyashi Basu, Julius M. Coon, et al.. (2010). Association of epithelial mesenchymal transition (EMT) markers and outcome measures in advanced non-small cell lung cancer (NSCLC) patients treated with erlotinib.. Journal of Clinical Oncology. 28(15_suppl). 7550–7550. 1 indexed citations

11.

He, Xijing, Mark Pool, Kathleen M. Darcy, et al.. (2007). Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene. 26(34). 4961–4968. 106 indexed citations

12.

Pool, Mark & Bruce C. McLeod. (1995). Pyrogen reactions to human serum albumin during plasma exchange. Journal of Clinical Apheresis. 10(2). 81–84. 14 indexed citations

13.

Pool, Mark, et al.. (1994). PCR Production of a Digoxigenin-labeled Probe for the Detection of Human Cytomegalovirus in Tissue Sections. Diagnostic Molecular Pathology. 3(3). 200–208. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact